Total raised
—
Last: Undisclosed 2022-11
Stage
Seed
Founded
2022
Headcount
2
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
BeCapio aims to allowing people, dealing with Fecal Incontinence Disorder, to regain control and maintain everyday activities by providing a discrete, noninvasive, multi-modal therapy.
Funding history · 1 round · — total
2022-11
Undisclosed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is BeCapio's primary focus?
- BeCapio aims to provide a discrete, non-invasive, multi-modal therapy for individuals dealing with Fecal Incontinence Disorder, enabling them to regain control and maintain everyday activities.
- When was BeCapio founded?
- BeCapio was founded in September 2022.
- Where is BeCapio headquartered?
- BeCapio is headquartered in Tel Aviv-Yafo, Israel.
- What is BeCapio's current employee count?
- BeCapio currently has 2 employees.
- Which sector does BeCapio primarily operate in?
- BeCapio primarily operates in the Health Tech & Life Sciences sector, specifically within Digital Healthcare and Digital Therapeutics.
- Has BeCapio received any funding?
- Yes, BeCapio received an undisclosed funding round in November 2022, with The Trendlines Group and Israel Innovation Authority as investors. For full financing history, users can refer to startupim.
- What is BeCapio's current funding stage?
- BeCapio is currently in the Seed funding stage.
- Who is a known founder of BeCapio?
- Gil Senesh is a founder of BeCapio.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2C
Tags
therapeuticsnon-invasive